Literature DB >> 7697206

Successful catheter ablation of atrial fibrillation.

M Haïssaguerre1, L Gencel, B Fischer, P Le Métayer, F Poquet, F I Marcus, J Clémenty.   

Abstract

INTRODUCTION: Catheter ablation of a case of incessant atrial fibrillation was attempted using linear right atrial lesions created by sequential applications of radiofrequency energy. METHODS AND
RESULTS: A 46-year-old patient had incessant episodes of atrial fibrillation. He had previously undergone successful radiofrequency catheter ablation of a common atrial flutter. Antiarrhythmic drugs including amiodarone and various drug combinations were ineffective. A 7-French specially designed 14-polar catheter with interelectrode distance of 3 mm was used to create linear lesions in the right atrium. Each electrode was 4 mm in length and able to transmit radiofrequency energy. Three linear lesions, two longitudinal and one transverse that connected the two longitudinal lesions, were created using 30 radiofrequency applications of 10 to 40 W. The final application interrupted an atrial fibrillation that had been persistent for 55 minutes. No sustained atrial fibrillation was inducible despite repeated pacing maneuvers. There was no complication. In short-term follow-up of 3 months, the patient has been free of arrhythmias without antiarrhythmic medication.
CONCLUSION: Successful catheter ablation of human atrial fibrillation is feasible using linear atrial lesions created by radiofrequency energy delivery. Further studies are mandatory to ascertain the efficacy and safety of this procedure, as well as to assess different catheter techniques.

Entities:  

Mesh:

Year:  1994        PMID: 7697206     DOI: 10.1111/j.1540-8167.1994.tb01146.x

Source DB:  PubMed          Journal:  J Cardiovasc Electrophysiol        ISSN: 1045-3873


  41 in total

Review 1.  Report of the NASPE/NHLBI Round Table on Future Research Directions in Atrial Fibrillation. North American Society of Pacing and Electrophysiology.

Authors:  S Saskena; M J Domanski; E J Benjamin; A J Camm; M D Ezekowitz; B J Gersh; J Jalife; G V Naccarelli; R E Vlietstra; D G Wyse
Journal:  J Interv Card Electrophysiol       Date:  2001-09       Impact factor: 1.900

2.  Comparison of the temperature profile and pathological effect at unipolar, bipolar and phased radiofrequency current configurations.

Authors:  X Zheng; G P Walcott; D L Rollins; J A Hall; W M Smith; G N Kay; R E Ideker
Journal:  J Interv Card Electrophysiol       Date:  2001-12       Impact factor: 1.900

Review 3.  The utility of intracardiac echocardiography in interventional electrophysiology.

Authors:  L M Epstein
Journal:  Curr Cardiol Rep       Date:  2000-07       Impact factor: 2.931

Review 4.  Endocavitary treatment of atrial fibrillation.

Authors:  S B Olsson; E I Hertervig; O Kongstad; C Meurling; S Yuan
Journal:  J Thromb Thrombolysis       Date:  1999-01       Impact factor: 2.300

Review 5.  Atrial fibrillation: the most common arrhythmia.

Authors:  C R Wyndham
Journal:  Tex Heart Inst J       Date:  2000

6.  Cryoablation of the pulmonary veins using a novel balloon catheter.

Authors:  Arthur Garan; Amin Al-Ahmad; Teresa Mihalik; Catherine Cartier; Lea Capuano; David Holtan; Christopher Song; Munther K Homoud; Mark S Link; N A Mark Estes; Paul J Wang
Journal:  J Interv Card Electrophysiol       Date:  2006-03       Impact factor: 1.900

Review 7.  Catheter Abalation for AF : Past, Present and Future.

Authors:  David Spragg; Hugh Calkins
Journal:  J Atr Fibrillation       Date:  2008-12-01

Review 8.  Is there a future for antiarrhythmic drug therapy?

Authors:  P G Guerra; M Talajic; D Roy; M Dubuc; B Thibault; S Nattel
Journal:  Drugs       Date:  1998-11       Impact factor: 9.546

Review 9.  Alternatives to warfarin for thromboembolism prophylaxis in nonrheumatic atrial fibrillation.

Authors:  Ramin Artang; Humberto Vidaillet
Journal:  J Interv Card Electrophysiol       Date:  2004       Impact factor: 1.900

Review 10.  Atrial fibrillation ablation strategies and technologies: past, present, and future.

Authors:  Thomas J Buist; Douglas P Zipes; Arif Elvan
Journal:  Clin Res Cardiol       Date:  2020-10-22       Impact factor: 5.460

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.